How to Buy Inhibrx Biosciences Stock
Inhibrx Biosciences Inc
Inhibrx Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.
Inhibrx Biosciences stock last closed at $128.79, down 0.33% from the previous day, and has increased 945.37% in one year. It has overperformed other stocks in the Biotechnology industry by 9.57 percentage points. Inhibrx Biosciences stock is currently +1,088.1% from its 52-week low of $10.84, and -17.06% from its 52-week high of $155.29.
At the moment, there are 14.61M shares of INBX outstanding. The market capitalization of INBX is $1.88B. In the past 24 hours, 327,000 INBX shares were traded.
How to Buy Inhibrx Biosciences Stock
Not sure how to invest in Inhibrx Biosciences stock? Here's how.
- Choose where to buy Inhibrx Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Inhibrx Biosciences stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Evaluate Inhibrx Biosciences stock: The Inhibrx Biosciences ticker symbol is INBX. Is Inhibrx Biosciences stock a good investment? Should you buy shares of INBX? How do INBX's underlying business fundamentals look? Do top analysts think Inhibrx Biosciences is a good buy? Why has INBX's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if INBX is a good stock to buy).
- Execute your INBX buy order: Decide if you will purchase INBX shares at the current market price or use a limit order to purchase INBX shares at a specific price.
- Get the latest scoop on your INBX position: Create a watchlist to monitor your position in Inhibrx Biosciences stock.
Step 1: Choose where to buy Inhibrx Biosciences stock
You need an online brokerage account to access the NASDAQ market and buy INBX shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal details so you can buy INBX today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've opened your account on a investment app, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details depositing money into your investment account.
Step 4: Evaluate Inhibrx Biosciences stock
Once you have identified the best place to buy Inhibrx Biosciences stock, it's important to evaluate their stock before you invest, so you truly comprehend the risk and upside.
Inhibrx Biosciences shares at a glance
Inhibrx Biosciences Overview
WallStreetZen was created to help average investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on INBX's stock page.
Is INBX stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge INBX's fair value.
Using relative valuations ratios:
- INBX could be overvalued based on its P/B ratio of 235.36x, relative to Biotechnology industry P/B ratio of 4.89x
You can access additional valuation research on INBX's stock here.
INBX Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the INBX balance sheet.
- There are more short-term assets than long-term liabilities on the INBX balance sheet.
Negative Health Checks:
- INBX has cash burn of 129822000. It does not have enough cash and short-term investments to cover this.
- INBX has a relatively high debt to equity ratio of 17.33.
- INBX has $124.22M in cash and short term investments. This is not sufficient to cover its annual cash burn of $129.82M.
- INBX profit margin has gone down from 843,786% to -10,773.5% in the past year.
Is it a good time to buy Inhibrx Biosciences stock, according to analysts?
Out of 1 Wall Street analysts who give ratings on INBX, the consensus analyst rating on Inhibrx Biosciences is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Inhibrx Biosciences stock forecast page.
INBX Momentum
INBX Revenue
Last year, INBX revenue was $1.30M. Over the past three year, INBX's revenue has grown by -74.1% per year. This was slower than the Biotechnology industry average of 26.82%.
You can analyze INBX's earnings and revenue performance here.
What are INBX executives and large shareholders up to?
In the past 12 months, executives and large shareholders at INBX have sold more shares than they have bought.
Viking Global Investors LP, 10% Owner of INBX, was the latest INBX insider to sell. They sold $9,953,736.75 worth of INBX shares on Oct 7, 2025.
Research more about who owns INBX shares here.
Does INBX stock generate passive income?
No, Inhibrx Biosciences doesn't provide an income stream by paying out dividends.
What do other traders have to say about INBX?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your INBX buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price limit, use a limit order.
Click the Open button and eToro will execute the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your INBX position
Now that you own some shares in INBX, you'll want to keep up with your new company.
Put INBX on a watchlist to monitor your INBX stock.
INBX Feed
How to Buy Stock in Inhibrx Biosciences
To summarize, here are the 6 steps you need to take to buy Inhibrx Biosciences stock right now:
- Choose where to buy Inhibrx Biosciences stock
- Open a brokerage account
- Deposit funds into your investment account
- Evaluate Inhibrx Biosciences stock
- Execute your INBX buy order
- Get the latest scoop on your INBX position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Inhibrx Biosciences, add INBX to your watchlist by clicking the button below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.